| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/01/1996 | WO1996002545A1 Heterocycle-condensed morphinoid derivatives |
| 02/01/1996 | WO1996002535A1 Process for synthesis of substituted sulphoxides |
| 02/01/1996 | WO1996002522A1 Natriuretic and anti-hypertensive compounds |
| 02/01/1996 | WO1996002520A1 Triazole compounds and their use as dopamine-d3-ligands |
| 02/01/1996 | WO1996002497A1 Substituted benzamidines, their production and their use as medicaments |
| 02/01/1996 | WO1996002496A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | WO1996002261A1 Use of magnesium hydroxide as a stool softener |
| 02/01/1996 | CA2195246A1 Growth differentiation factor-12 |
| 02/01/1996 | CA2194886A1 Novel chemical compound, its preparation and use as a drug |
| 02/01/1996 | CA2194877A1 Heterocycle-condensed morphinoid derivatives |
| 01/31/1996 | EP0694546A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694545A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| 01/31/1996 | EP0694535A1 Non-peptidyl tachykinin receptor antagonists |
| 01/31/1996 | EP0694299A1 The use of( a) bicycloheptane derivative(s) |
| 01/31/1996 | EP0694040A1 1,5 benzodiazepine derivatives having cck and/or gastrin antagonistic activity |
| 01/31/1996 | EP0608353B1 LOW pH AQUEOUS COSMETIC GEL CONTAINING NON-IONIC POLYACRYLAMIDE DERIVATIVES |
| 01/31/1996 | CN1115981A New chemopreventive compounds and a preparation method and use thereof |
| 01/31/1996 | CN1115669A Orally-taken Chinese medicine for curing appendicitis |
| 01/30/1996 | US5488151 {(7S)-7-[(2R)-2-(3-chlorophenyl)-2-hydroxyethylamino)-2-hydroxyethylamino]5,} acetic acid and its pharmaceutically acceptable salts |
| 01/30/1996 | US5488062 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 01/30/1996 | CA2055905C Pharmaceutical composition comprising calcium polycarbophil |
| 01/30/1996 | CA2031572C Non-alcoholic delivery system for orally ingestible active ingredients |
| 01/30/1996 | CA2001004C Antiemesis ergoline derivatives |
| 01/26/1996 | WO1996001625A1 Multiple unit tableted dosage form containing proton pump inhibitor |
| 01/26/1996 | CA2170995A1 Multiple unit tableted dosage form containing proton pump inhibitor |
| 01/25/1996 | WO1996001824A1 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product |
| 01/25/1996 | WO1996001822A1 Anti-helicobacter acyl derivatives of azolones |
| 01/25/1996 | WO1996001821A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 01/25/1996 | WO1996001820A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 01/25/1996 | WO1996001819A1 Heterocyclic tachykinin receptor antagonists |
| 01/25/1996 | WO1996001818A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 01/25/1996 | WO1996001817A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/25/1996 | WO1996001646A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | WO1996001624A1 Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 01/25/1996 | WO1996001623A1 Multiple unit tableted dosage form i |
| 01/25/1996 | CA2194565A1 Anti-helicobacter urea and thiourea derivatives of azolones |
| 01/25/1996 | CA2194563A1 Anti-helicobacter heterocyclic derivatives of azolones |
| 01/25/1996 | CA2194562A1 Sulfonamide derivatives of azolones anti-helicobacter agents |
| 01/25/1996 | CA2194550A1 Invariant chain compositions useful for treating autoimmune diseases |
| 01/25/1996 | CA2193681A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 01/25/1996 | CA2193490A1 Anti-helicobacter acyl derivatives of azolones |
| 01/25/1996 | CA2188680A1 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 01/24/1996 | EP0693489A1 Heterocyclic tachykinin receptor antagonists |
| 01/24/1996 | EP0693059A1 Perhydroisoindole derivatives, preparation thereof and pharmaceutical compositions containing same |
| 01/24/1996 | EP0693053A1 Urea and amide derivatives and their use in the control of cell membrane potassium channels |
| 01/24/1996 | EP0692971A1 Analogs of peptide yy and uses thereof |
| 01/24/1996 | CN1115230A Material for clearing decayed tooth and tartar removing composn. |
| 01/23/1996 | US5486623 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 01/23/1996 | US5486528 Antiulcer agents, anxiolytic agents |
| 01/23/1996 | US5486520 1,3-oxathiolanes useful in the treatment of hepatitis |
| 01/23/1996 | US5486514 Carbamate derivatives |
| 01/23/1996 | CA2154116A1 1-aryl-2-acetamidopentanone derivatives for use as tachykinin receptor antagonists |
| 01/23/1996 | CA1337991C Basically substituted phenylacetonitriles, their preparation and drugs containing these compounds |
| 01/20/1996 | CA2154201A1 Use of magnesium hydroxide as a stool softener |
| 01/18/1996 | WO1996001316A1 NOVEL GROWTH OR DIFFERENTIATION FACTOR OF THE TGF-β FAMILY |
| 01/18/1996 | WO1996001273A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/18/1996 | WO1996001272A1 Helicobacter proteins and vaccines |
| 01/18/1996 | WO1996001270A1 Human elastase iv |
| 01/18/1996 | WO1996001115A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 01/18/1996 | DE4425144A1 Triazolverbindungen und deren Verwendung Triazole compounds and the use thereof |
| 01/18/1996 | DE4424714A1 Neue chemische Verbindung, ihre Herstellung und ihre Verwendung als Arnzneistoff New chemical compound, their preparation and their use as Arnzneistoff |
| 01/18/1996 | DE4424713A1 Substituierte Benzamidine, ihre Herstellung und Verwendung als Arnzneistoffe Substituted benzamidines, their preparation and use as Arnzneistoffe |
| 01/18/1996 | CA2194391A1 Human elastase iv |
| 01/18/1996 | CA2194237A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 01/17/1996 | EP0692490A2 Recombinant Alzheimer's amyloid protein protease inhibitor |
| 01/17/1996 | EP0692472A1 Alpha-(4-chlorophenyl)- 4-(4-fluorophenylmethyl)-piperidine-1 -ethanol esters, their preparation and therapeutical use |
| 01/17/1996 | EP0692457A2 A hexagonal molecular structure water manufacturing apparatus and a method thereof |
| 01/17/1996 | EP0692255A2 Antacid preparation with improved safety profile |
| 01/17/1996 | EP0692024A1 AN $g(a)-GALACTOSIDASE ENZYME |
| 01/17/1996 | EP0691973A1 THIENO-INDOLE DERIVATIVES AS 5HT2c AND 5HT2b ANTAGONISTS |
| 01/17/1996 | EP0554381B1 Use of protective agents against reactive oxygen species |
| 01/17/1996 | CN1114961A Peptide inhibitors of cell adhesion |
| 01/17/1996 | CN1114957A New (thia)cycloalkyl|b¨indole compounds, process for the preparation thereof, and pharmaceutical compositions containing them |
| 01/17/1996 | CN1114890A Traditional Chinese medicine preparation for regulating taste, benefitting liver and kidney and improving intelligence |
| 01/17/1996 | CN1030718C Superoxide dismutase |
| 01/17/1996 | CN1030703C Neurokinin A antagonists |
| 01/16/1996 | US5484810 Tissue protective tocopherol analogs |
| 01/16/1996 | US5484609 Therapeutic compositions and methods |
| 01/16/1996 | US5484595 Process for preparation of dibenzocyclooctadiene type lignan |
| 01/16/1996 | CA1337931C Treatment of periodontoclasia with retinoic acid |
| 01/14/1996 | CA2153726A1 .alpha.-(4-chlorophenyl)-4-[(4-fluorophenyl)-methyl]piperidine-1- ethanol esters, their preparation and their therapeutic application |
| 01/14/1996 | CA2153567A1 Antacid formulation having an improved safety profile |
| 01/11/1996 | WO1996000738A1 Endothelin antagonists ii |
| 01/11/1996 | WO1996000732A1 Phosphinic acid derivatives |
| 01/11/1996 | WO1996000580A1 Health composition |
| 01/11/1996 | CA2193104A1 Pharmaceutical compositions containing triclosan or derivatives thereof and edta or egta |
| 01/11/1996 | CA2190756A1 Endothelin antagonists ii |
| 01/10/1996 | EP0691341A1 Benzopyrancarboxamide derivatives, salt thereof, process for the preparation of same and use thereof |
| 01/10/1996 | EP0691340A1 1-Azabicyclo 3.3.0 octan derivative, salt thereof, process for the preparation of same and use thereof |
| 01/10/1996 | EP0691128A1 Methods of administering CRF antagonists |
| 01/10/1996 | EP0690872A1 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 01/10/1996 | EP0690863A1 Tetracyclic compounds as dopamine agonists |
| 01/10/1996 | EP0690849A1 Heterocycle-containing amidine derivatives, their preparation and use |
| 01/10/1996 | EP0690719A1 Dry mix formulation for bisphosphonic acids |
| 01/10/1996 | EP0690717A1 Use of oligosaccharide glycosides as inhibitors of bacterial adherence |
| 01/09/1996 | US5482941 Quinazolinone antianginal agents |
| 01/09/1996 | US5482926 Growth factor IGF-Il |
| 01/04/1996 | WO1996000214A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 01/04/1996 | WO1996000205A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 01/04/1996 | WO1996000081A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |